6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazepin-​6-​one, 5,​11-​dihydro-​2-​[[2-​methoxy-​4-​(4-​methyl-​1-​piperazinyl)​phenyl]​amino]​-​5,​11-​dimethyl- - CAS 1234479-76-5
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazepin-​6-​one, 5,​11-​dihydro-​2-​[[2-​methoxy-​4-​(4-​methyl-​1-​piperazinyl)​phenyl]​amino]​-​5,​11-​dimethyl-
Catalog Number:
1234479-76-5
Synonyms:
CHEMBL1673039; SCHEMBL618262; BDBM50337127; ZINC66066276; CS-4938; HY-14403
CAS Number:
1234479-76-5
Description:
An effective inhibitior of ERK5, could probably be used as an antitumor agent. IC50: 0.19μM(EC50 for cellular),of 0.087 μM(for enzymatic) and 0.087 μM(for LRRK2).
Molecular Weight:
459.54
Molecular Formula:
C25H29N7O2
Quantity:
Milligrams-Grams
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C)OC
InChI:
InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)
InChIKey:
DDTPGANIPBKTNU-UHFFFAOYSA-N
Targets:
ERK
Chemical Structure
CAS 1234479-76-5 6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazepin-​6-​one, 5,​11-​dihydro-​2-​[[2-​methoxy-​4-​(4-​methyl-​1-​piperazinyl)​phenyl]​amino]​-​5,​11-​dimethyl-

Related ERK Products


CAS 35807-85-3 Sodium Tauroursodeoxycholate (TUDC)

Sodium Tauroursodeoxycholate (TUDC)
(CAS: 35807-85-3)

Sodium Tauroursodeoxycholate (TUDC) is a water soluble bile salt, used for the treatment of gallstones and liver cirrhosis.

DEL-22379
(CAS: 181223-80-3)

DEL-22379 is a water-soluble ERK dimerization inhibitor with IC50 of ∼0.5 μM.

CAS 1435488-37-1 XMD17-109

XMD17-109
(CAS: 1435488-37-1)

Potent and selective ERK5 inhibitor; inhibits EGFR-induced ERK5 autophosphorylation (EC50 = 90 nM) and ERK5 enzymatic activity (IC50 = 162 nM). Exhibits at leas...

CAS 942183-80-4 SCH772984

SCH772984
(CAS: 942183-80-4)

SCH772984 is an potent and selective ERK inhibitor with potential anticancer activity. SCH722984 showed activity against BRAF mutant, NRAS mutant and wild-type ...

CAS 1234479-76-5 6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazepin-​6-​one, 5,​11-​dihydro-​2-​[[2-​methoxy-​4-​(4-​methyl-​1-​piperazinyl)​phenyl]​amino]​-​5,​11-​dimethyl-

6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazep
(CAS: 1234479-76-5)

An effective inhibitior of ERK5, could probably be used as an antitumor agent. IC50: 0.19μM(EC50 for cellular),of 0.087 μM(for enzymatic) and 0.087 μM(for LRRK2...

CAS 1616632-77-9 TIC-10 (ON201)

TIC-10 (ON201)
(CAS: 1616632-77-9)

TIC10, also known as ONC201, is a potent, orally active, and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses ...

CAS 1453848-26-4 GDC-0994

GDC-0994
(CAS: 1453848-26-4)

GDC-0994, also known as RG7842, is an orally available inhibitor of extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon or...

CAS 630-94-4 Corynoxeine

Corynoxeine
(CAS: 630-94-4)

Corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and a useful and prospective compound in the prevention and treatment for vas...

CAS 896720-20-0 VX-11e

VX-11e
(CAS: 896720-20-0)

VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK, which is extracellular signal-regulated kinases. It is an antitumor agent and potently ...

CAS 1234480-50-2 XMD8-92

XMD8-92
(CAS: 1234480-50-2)

XMD8-92, via inhibition of BMK1 activation, significantly induces p21 expression in cells, and mediates suppression of cancer cell proliferation.

CAS 869886-67-9 Ulixertinib

Ulixertinib
(CAS: 869886-67-9)

Ulixertinib, also known as VRT752271, is an inhibitors of ERK protein kinase.

CAS 865362-74-9 FR180204

FR180204
(CAS: 865362-74-9)

FR180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis.FR1802...

CAS 41276-02-2 TIC10

TIC10
(CAS: 41276-02-2)

TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability an...